Key result
TCR V-beta DNA vaccination reduces experimental autoimmune encephalomyelitis mortality to 0% versus control.
Why the study?
Does intradermal vaccination with DNA encoding for the T-cell receptor reduce clinical scores and mortality in a B10.PL mouse model of experimental autoimmune encephalomyelitis?
Does intradermal vaccination with DNA encoding for the T-cell receptor reduce clinical scores and mortality in a B10.PL mouse model of experimental autoimmune encephalomyelitis?
Absolute Event Rate: 0% vs 50%
Absolute Risk Reduction: 50%
p-value: p=<0.05
Intradermal DNA vaccination encoding for TCR reduces clinical severity and mortality in a mouse model of experimental autoimmune encephalomyelitis, suggesting potential utility for autoimmune diseases.
May protect against EAE mortality in mice; leaves open translation to human autoimmune disease.
Intradermal gene administration was found to induce a more profound immune response than direct intramuscular gene injection. We performed intradermal vaccination of B10.PL mice with DNA encoding for the V 8.2 region of the T-cell receptors (TCR). Three weeks later, these mice were immunized with rat myelin basic protein (MBP). Daily mean clinical scores and mortality rate were lower in this group compared with controls. The proliferative responses of lymph node cells to rat MBP were slightly less in the vaccination groups than in the control groups (p < 0.05). However, we detected no differences between the two groups with regard to the production of MBP-specific IgG, IgG1, & IgG2a antibodies. The levels of cytokine mRNA expression in the vaccination groups were observed higher than in the control groups without antigen-specific stimulation, but all of cytokine expressions between the vaccination and control groups after antigen-specific stimulation were identical. These results demonstrate that intradermal DNA vaccines encoding for TCR might prove to be useful in the control of autoimmune disease.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2005) studied Experimental Autoimmune Encephalomyelitis (EAE) (n=40). Intradermal vaccination with DNA encoding for TCR V beta 8.2 vs. pcDNA3.1 blank vector was evaluated on Mortality rate due to severe clinical EAE (p=<0.05). Intradermal vaccination with DNA encoding for the TCR V beta 8.2 region significantly reduced the mortality rate of experimental autoimmune encephalomyelitis to 0% compared to 50% in the control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: